Histamine is required for H3 receptor-mediated alcohol reward inhibition, but not for alcohol consumption or stimulation

British Journal of Pharmacology

Volumn 170, Issue 1, 2013, Pages 177-187

  Vanhanen, J ^a   Nuutinen, S ^a   Lintunen, M ^b   Maki T ^a   Ramo J ^a   Karlstedt, K ^a,b   Panula, P ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b ÅBO AKADEMI UNIVERSITY   (Finland)

Author keywords

alcohol; dopamine; H3 receptor antagonist; histamine; reward

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; HISTAMINE; HISTAMINE H3 RECEPTOR; MESSENGER RNA; PHOSPHOPROTEIN DARPP 32;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DARPP 32 GENE; DOPAMINE D1 RECEPTOR GENE; DOPAMINE D2 RECEPTOR GENE; FEMALE; GENE DELETION; GENE EXPRESSION; HISTAMINE RELEASE; IN SITU HYBRIDIZATION; INHIBITION (PSYCHOLOGY); LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REWARD; STEP61 GENE; WILD TYPE;

ALCOHOL; DOPAMINE; H3 RECEPTOR ANTAGONIST; HISTAMINE; REWARD;

ALCOHOL DRINKING; ANIMALS; AZEPINES; CONDITIONING (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; HISTAMINE; HISTAMINE H3 ANTAGONISTS; HISTAMINE RELEASE; HISTIDINE DECARBOXYLASE; IN SITU HYBRIDIZATION; MALE; MICE; MICE, INBRED DBA; MICE, KNOCKOUT; MORPHOLINES; MOTOR ACTIVITY; NEURONS; PIPERIDINES; PYRIDINES; RECEPTORS, HISTAMINE H3; REWARD; RNA, MESSENGER;

EID: 84881620668     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12170     Document Type: Article

References (63)

1. Alexander, SPH, Mathie A, Peter JA, (2011). Guide to Receptors and Channels (GRAC), 5th edition. Br J Pharmacol 164 (Suppl. S1): S1-S324.
2. Airaksinen MS, Paetau A, Paljarvi L, Reinikainen K, Riekkinen P, Suomalainen R, et al. (1991a). Histamine neurons in human hypothalamus: anatomy in normal and Alzheimer diseased brains. Neuroscience 44: 465-481.
3. Airaksinen MS, Reinikainen K, Riekkinen P, Panula P, (1991b). Neurofibrillary tangles and histamine-containing neurons in Alzheimer hypothalamus. Agents Actions 33: 104-107.
4. Alakarppa K, Tupala E, Mantere T, Sarkioja T, Rasanen P, Tarhanen J, et al. (2002). Effect of alcohol abuse on human brain histamine and tele-methylhistamine. Inflamm Res 51: 40-41.
5. Alakarppa K, Tupala E, Mantere T, Sarkioja T, Rasanen P, Tarhanen J, et al. (2003). Alcoholics show altered histaminergic neurotransmission in several cortical areas-preliminary report. Inflamm Res 52: 37-38.
6. Anichtchik OV, Rinne JO, Kalimo H, Panula P, (2000). An altered histaminergic innervation of the substantia nigra in Parkinson's disease. Exp Neurol 163: 20-30.
7. Anichtchik OV, Peitsaro N, Rinne JO, Kalimo H, Panula P, (2001). Distribution and modulation of histamine H(3) receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease. Neurobiol Dis 8: 707-716.
8. Beninger RJ, (1983). The role of dopamine in locomotor activity and learning. Brain Res 287: 173-196.
9. Bonaventure P, Letavic M, Dugovic C, Wilson S, Aluisio L, Pudiak C, et al. (2007). Histamine H3 receptor antagonists: from target identification to drug leads. Biochem Pharmacol 73: 1084-1096.
10. Brabant C, Quertemont E, Anaclet C, Lin JS, Ohtsu H, Tirelli E, (2007). The psychostimulant and rewarding effects of cocaine in histidine decarboxylase knockout mice do not support the hypothesis of an inhibitory function of histamine on reward. Psychopharmacology 190: 251-263.
11. Brabant C, Alleva L, Quertemont E, Tirelli E, (2010). Involvement of the brain histaminergic system in addiction and addiction-related behaviors: a comprehensive review with emphasis on the potential therapeutic use of histaminergic compounds in drug dependence. Prog Neurobiol 92: 421-441.
12. Cacabelos R, Yamatodani A, Niigawa H, Hariguchi S, Tada K, Nishimura T, et al. (1989). Brain histamine in Alzheimer's disease. Methods Find Exp Clin Pharmacol 11: 353-360.
13. Chepkova A, Yanovsky E, Parmentier R, Ohtsu H, Haas HL, Lin J, et al. (2012). Histamine receptor expression, hippocampal plasticity and ammonia in histidine decarboxylase knockout mice. Cell Mol Neurobiol 32: 17-25.
14. Cohn CK, Ball GG, Hirsch J, (1973). Histamine: effect on self stimulation. Science 180: 757-758.
15. Cunningham CL, Noble D, (1992). Conditioned activation induced by ethanol: role in sensitization and conditioned place preference. Pharmacol Biochem Behav 43: 307-313.
16. Cunningham CL, Gremel CM, Groblewski PA, (2006). Drug-induced conditioned place preference and aversion in mice. Nat Protoc 1: 1662-1670.
17. Di Chiara G, Imperato A, (1985). Ethanol preferentially stimulates dopamine release in the nucleus accumbens of freely moving rats. Eur J Pharmacol 115: 131-132.
18. Drutel G, Peitsaro N, Karlstedt K, Wieland K, Smit MJ, Timmerman H, et al. (2001). Identification of rat H3 receptor isoforms with different brain expression and signaling properties. Mol Pharmacol 59: 1-8.
19. Ellender TJ, Huerta-Ocampo I, Deisseroth K, Capogna M, Paul Bolam J, (2011). Differential modulation of excitatory and inhibitory striatal synaptic transmission by histamine. J Neurosci 31: 15340-15351.
20. Ercan-Sencicek AG, Stillman AA, Ghosh AK, Bilguvar K, O'Roak BJ, Mason CE, et al. (2010). L-histidine decarboxylase and Tourette's syndrome. N Engl J Med 362: 1901-1908.
21. Fernandez TV, Sanders SJ, Yurkiewicz IR, Ercan-Sencicek AG, Kim YS, Fishman DO, et al. (2012). Rare copy number variants in tourette syndrome disrupt genes in histaminergic pathways and overlap with autism. Biol Psychiatry 71: 392-402.
22. Ferrada C, Ferre S, Casado V, Cortes A, Justinova Z, Barnes C, et al. (2008). Interactions between histamine H3 and dopamine D2 receptors and the implications for striatal function. Neuropharmacology 55: 190-197.
23. Ferrada C, Moreno E, Casado V, Bongers G, Cortes A, Mallol J, et al. (2009). Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors. Br J Pharmacol 157: 64-75.
24. Galici R, Boggs JD, Aluisio L, Fraser IC, Bonaventure P, Lord B, et al. (2009). JNJ-10181457, a selective non-imidazole histamine H(3) receptor antagonist, normalizes acetylcholine neurotransmission and has efficacy in translational rat models of cognition. Neuropharmacology 56: 1131-1137.
25. Galici R, Rezvani AH, Aluisio L, Lord B, Levin ED, Fraser I, et al. (2011). JNJ-39220675, a novel selective histamine H3 receptor antagonist, reduces the abuse-related effects of alcohol in rats. Psychopharmacology 214: 829-841.
26. Gremel CM, Cunningham CL, (2007). Role of test activity in ethanol-induced disruption of place preference expression in mice. Psychopharmacology (Berl) 191: 195-202.
27. Haas H, Panula P, (2003). The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci 4: 121-130.
28. Henwood RW, Mazurikiewicz-Kwilecki IM, (1975). Possible role of brain histamine in morphine addiction. Life Sci 17: 55-56.
29. Huston JP, Wagner U, Hasenöhrl RU, (1997). The tuberomammillary nucleus projections in the control of learning, memory and reinforcement processes: evidence for an inhibitory role. Behav Brain Res 83: 97-105.
30. Kathmann M, Schlicker E, Marr I, Werthwein S, Stark H, Schunack W, (1998). Ciproxifan and chemically related compounds are highly potent and selective histamine H3-receptor antagonists. Naunyn Schmiedebergs Arch Pharmacol 358: 623-627.
31. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). NC3Rs Reporting Guidelines Working Group. Br J Pharmacol 160: 1577-1579.
32. Korotkova TM, Haas HL, Brown RE, (2002). Histamine excites GABAergic cells in the rat substantia nigra and ventral tegmental area in vitro. Neurosci Lett 320: 133-136.
33. Letavic MA, Aluisio L, Atack JR, Bonaventure P, Carruthers NI, Dugovic C, et al. (2010). Pre-clinical characterization of aryloxypyridine amides as histamine H3 receptor antagonists: identification of candidates for clinical development. Bioorg Med Chem Lett 20: 4210-4214.
34. Lintunen M, Sallmen T, Karlstedt K, Fukui H, Eriksson KS, Panula P, (1998). Postnatal expression of H1-receptor mRNA in the rat brain: correlation to L-histidine decarboxylase expression and local upregulation in limbic seizures. Eur J Neurosci 10: 2287-2301.
35. Lintunen M, Hyytia P, Sallmen T, Karlstedt K, Tuomisto L, Leurs R, et al. (2001). Increased brain histamine in an alcohol-preferring rat line and modulation of ethanol consumption by H(3) receptor mechanisms. FASEB J 15: 1074-1076.
36. McGrath J, Drummond G, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
37. Mazurkiewicz-Kwilecki I, Henwood RW, (1976). Alterations in brain endogenous histamine levels in rats after chronic morphine treatment and morphine withdrawal. Agents Actions 6: 402-408.
38. Mazurkiewicz-Kwilecki IM, Nsonwah S, (1989). Changes in the regional brain histamine and histidine levels in postmortem brains of Alzheimer patients. Can J Physiol Pharmacol 67: 75-78.
39. Mogenson GJ, Yang CR, (1991). The contribution of basal forebrain to limbic-motor integration and the mediation of motivation to action. Adv Exp Med Biol 295: 267-290.
40. Molina-Hernandez A, Nunez A, Arias-Montano JA, (2000). Histamine H3-receptor activation inhibits dopamine synthesis in rat striatum. Neuroreport 11: 163-166.
41. Monnier M, Fallert M, Battacharya IC, (1967). The waking action of histamine. Experientia 23: 21-22.
42. Moreno E, Hoffmann H, Gonzalez-Sepulveda M, Navarro G, Casado V, Cortes A, et al. (2011). Dopamine D1-histamine H3 receptor heteromers provide a selective link to MAPK signaling in GABAergic neurons of the direct striatal pathway. J Biol Chem 286: 5846-5854.
43. Nakai T, Kitamura N, Hashimoto T, Kajimoto Y, Nishino N, Mita T, et al. (1991). Decreased histamine H1 receptors in the frontal cortex of brains from patients with chronic schizophrenia. Biol Psychiatry 30: 349-356.
44. Nuutinen S, Karlstedt K, Aitta-Aho T, Korpi ER, Panula P, (2010). Histamine and H3 receptor-dependent mechanisms regulate ethanol stimulation and conditioned place preference in mice. Psychopharmacology 208: 75-86.
45. Nuutinen S, Lintunen M, Vanhanen J, Ojala T, Rozov S, Panula P, (2011a). Evidence for the role of histamine H3 receptor in alcohol consumption and alcohol reward in mice. Neuropsychopharmacology 36: 2030-2040.
46. Nuutinen S, Vanhanen J, Pigni MC, Panula P, (2011b). Effects of histamine H3 receptor ligands on the rewarding, stimulant and motor-impairing effects of ethanol in DBA/2J mice. Neuropharmacology 60: 1193-1199.
47. Nuutinen S, Vanhanen J, Mäki T, Panula P, (2012). Histamine H3 receptor: a novel therapeutic target in alcohol dependence? Front Syst Neurosci 6: 1-7.
48. Ohtsu H, Tanaka S, Terui T, Hori Y, Makabe-Kobayashi Y, Pejler G, et al. (2001). Mice lacking histidine decarboxylase exhibit abnormal mast cells. FEBS Lett 502: 53-56.
49. Olds J, Milner P, (1954). Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J Comp Physiol Psychol 47: 419-427.
50. Panula P, Nuutinen S, (2011). Histamine and H3 receptor in alcohol-related behaviors. J Pharmacol Exp Ther 336: 9-16.
51. Panula P, Rinne J, Kuokkanen K, Eriksson KS, Sallmen T, Kalimo H, et al. (1998). Neuronal histamine deficit in Alzheimer's disease. Neuroscience 82: 993-997.
52. Perreault ML, Hasbi A, Alijaniaram M, Fan T, Varghese G, Fletcher PJ, et al. (2010). The dopamine D1-D2 receptor heteromer localizes in dynorphin/enkephalin neurons: increased high affinity state following amphetamineandin schizophrenia. J Biol Chem 285: 36625-36634.
53. Phillips TJ, Brown KJ, Burkhart-Kasch S, Wenger CD, Kelly MA, Rubinstein M, et al. (1998). Alcohol preference and sensitivity are markedly reduced in mice lacking dopamine D2 receptors. Nat Neurosci 1: 610-615.
54. Pillot C, Heron A, Cochois V, Tardivel-Lacombe J, Ligneau X, Schwartz JC, et al. (2002). A detailed mapping of the histamine H(3) receptor and its gene transcripts in rat brain. Neuroscience 114: 173-193.
55. Prell GD, Green JP, Kaufmann CA, Khandelwal JK, Morrishow AM, Kirch DG, et al. (1995). Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms. Schizophr Res 14: 93-104.
56. Rhodes JS, Best K, Belknap JK, Finn DA, Crabbe JC, (2005). Evaluation of a simple model of ethanol drinking to intoxication in C57BL/6J mice. Physiol Behav 84: 53-63.
57. Rinne JO, Anichtchik OV, Eriksson KS, Kaslin J, Tuomisto L, Kalimo H, et al. (2002). Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy. J Neurochem 81: 954-960.
58. Sakata T, Fukagawa K, Ookuma K, Fujimoto K, Yoshimatsu H, Yamatodani A, et al. (1988). Modulation of neuronal histamine in control of food intake. Physiol Behav 44: 539-543.
59. Sanchez-Lemus E, Arias-Montano JA, (2004). Histamine H3 receptor activation inhibits dopamine D1 receptor-induced cAMP accumulation in rat striatal slices. Neurosci Lett 364: 179-184.
60. Vallone D, Picetti R, Borrelli E, (2000). Structure and function of dopamine receptors. Neurosci Biobehav Rev 24: 125-132.
61. Wise RA, (2009). Roles for nigrostriatal -not just mesocorticolimbic- dopamine in reward and addiction. Trends Neurosci 32: 517-524.
62. Wong CL, (1975). Possible role of brain histamine and H1 and H2 receptors in development of morphine-tolerance and physical-dependence in mice. Agents Actions 5: 476-483.
63. Yim HJ, Schallert T, Randall PK, Gonzales RA, (1998). Comparison of local and systemic ethanol effects on extracellular dopamine concentration in rat nucleus accumbens by microdialysis. Alcohol Clin Exp Res 22: 367-374.